These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17419357)

  • 1. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
    Okunevich IV; Khnychenko LK; Sapronov NS
    Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of thyroid pathology in pathogenesis of arterial hypertension in diabetes].
    Tereshchenko IV; Trefilova ES
    Klin Med (Mosk); 2002; 80(10):21-4. PubMed ID: 12471832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the choice of pharmacotherapy for the treatment of arterial hypertension in elderly patients with diabetes mellitus].
    Burtsev VI; Kochnova VA
    Klin Med (Mosk); 1997; 75(9):30-2. PubMed ID: 9432537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset diabetes during antihypertensive therapy.
    Alderman MH
    Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.
    Mogensen CE
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S15-20. PubMed ID: 16075028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension].
    Leviashvili BI
    Klin Med (Mosk); 1989 Mar; 67(3):34-7. PubMed ID: 2747151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of arterial hypertension in diabetes mellitus. Choices and problems].
    Orsini S; Allegri L; Castiglioni A; Garini G; Vinci S; Savazzi G
    Recenti Prog Med; 1993 Dec; 84(12):873-83. PubMed ID: 8108603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
    Onuchin SG; Elsukova OS; Onuchina EL
    Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive agents and the risk of new onset diabetes mellitus].
    Kuzmanić D; Laganović M; Dika Z; Kos J; Pećin I
    Lijec Vjesn; 2006; 128(11-12):336-41. PubMed ID: 17212194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
    Bakris G; Hester A; Weber M; Dahlof B; Pitt B; Velasquez E; Staikos-Byrne L; Shi V; Jamerson K;
    J Cardiometab Syndr; 2008; 3(4):229-33. PubMed ID: 19040592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in pharmacotherapy of hypertension 1989-1996 in patients with diabetes mellitus].
    Vlha R; Hellerová J; Vlhová V
    Vnitr Lek; 1998 Apr; 44(4):212-6. PubMed ID: 9820105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
    Kudoh T; Nagawaga T; Nakagawa I
    Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.